Anzeige
++++++ Nasdaq springt nach oben - Jetzt lohnt der Blick über die üblichen Namen hinaus ++++++
Portfolio Tracker
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
Original-Research

GFT Technologies SE (von NuWays AG): BUY 04.11.2026, 09:00 Uhr von dpa-AFX Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
GFT Technologies 27,58 EUR -0,45 % Baader Bank
Kostenlose Aktienchance per SMS Ausgewählte Trading-Einschätzungen aufs Handy.

Original-Research: GFT Technologies SE - from NuWays AG



04.11.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS
Group.
The issuer is solely responsible for the content of this research. The
result of this research does not constitute investment advice or an
invitation to conclude certain stock exchange transactions.



---------------------------------------------------------------------------



Classification of NuWays AG to GFT Technologies SE



     Company Name:                GFT Technologies SE
     ISIN:                        DE0005800601



     Reason for the research:     Update
     Recommendation:              BUY
     Target price:                EUR 32
     Target price on sight of:    12 months
     Last rating change:
     Analyst:                     Simon Keller



Q3 preview: code for a comeback, chg.



GFT's Q3 should put earnings upside back in focus. Faster growth and
improving UK profitability suggest that the 2026 guidance is too
conservative. Our forecast still allows for a slowdown in Q4 earnings
growth, leaving room for outperformance.



Peer results highlight continued IT spending by financial institutions.
Accenture's Financial Services revenue grew 6% yoy in local currency in
fiscal Q4. Cognizant's corresponding segment grew c. 8% yoy in constant
currencies in Q3, excluding the contribution from third-party product sales.
On 30 October, Capgemini raised its FY26 revenue outlook, implying 4-4.5%
organic growth, and highlighted Financial Services as a growth driver. While
Accenture's group FY27 guidance remains measured, implying 0.5-4% organic
growth (+2-2.5pp from acquisitions), the company highlights ongoing
investment in core systems and data infrastructure needed for AI adoption.
These spending priorities should support demand for GFT's banking, cloud and
data expertise (eNuW).



GFT's Q3 sales growth should accelerate. Revenues look set to grow 7.6% yoy
to EUR 230m, following 6.1% yoy growth in Q2. Latin America should remain the
main growth driver and we expect the UK to grow both yoy and qoq against a
weak comp following its restructuring.



Q3 adj. EBIT should grow faster than sales. Adj. EBIT is expected to grow
16.9% yoy to EUR 18m, implying a margin improvement of 0.6pp yoy to 7.8%.
Improving UK profitability, greater personnel efficiency and lower office
lease depreciation should drive the increase (eNuW).



FY26 guidance looks too conservative. Based on our Q3 estimates, the EUR 71m
adj. EBIT target implies a c. 7% yoy decline in Q4, compared with c. 17%
growth expected for Q3. Continued improvements in UK profitability and
personnel efficiency underpin our higher FY26 forecast of EUR 73m (eNuW).



Sustained delivery would mark a change in the earnings-revision trend.
Following repeated guidance cuts in 2023-25, an outlook with room for
outperformance represents a meaningful improvement. While our forecast still
assumes only c. 3% yoy adj. EBIT growth in Q4, ongoing momentum into
year-end could help GFT exceed both guidance and our estimates. Sustained
delivery would also help rebuild confidence in the earnings trajectory
beyond FY26 (eNuW).



The investment case extends beyond the UK recovery. GFT's banking expertise
and deep knowledge of clients' complex IT systems create switching costs and
support follow-on business as banks modernise their core platforms to enable
AI. Expanding smartshore delivery and shifting towards higher-value services
offer structural margin upside. Its capital-light business model also
supports cash generation.



Action: adj. EBIT increased by c. 3% for 2026e, supported by FX and positive
peer cross reads.



BUY, with a PT of EUR 32, based on DCF.



You can download the research here:
https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&u=4c7e1a5b1dcb833a977c1fa36d377fbc
For additional information visit our website:
https://www.nuways-ag.com/research



Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss
bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben
analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++



---------------------------------------------------------------------------



The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
View original content:
https://eqs-news.com/?origin_id=2f6b3695-d81e-11f1-b46d-066675bb9927&lang=en



---------------------------------------------------------------------------



2427946 04.11.2026 CET/CEST




Kommentare (0) ... diskutiere mit.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer